|
MechanismTGF-β inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Senelix Co. Ltd.
0 Patents (Medical) associated with Senelix Co. Ltd.
100 Deals associated with Senelix Co. Ltd.
100 Translational Medicine associated with Senelix Co. Ltd.